Oct4, Sox2, Nanog, Bmi1, and Klf4 were expressed in 15.4%, 10.3%, 20.4%, 50.5%, and 17.6% of tumor samples, respectively (Figure 1). This evidence concerns the gene BMI1 and neoplasm.